Skip to main content

digital health regulation

By Dave Muoio | 12:19 pm | November 19, 2018
The agency's proposal would classify the majority of software released by pharmas as "promotional labeling" that would not require premarket review.  
By Jonah Comstock | 11:32 am | September 17, 2018
The results to our poll about the FDA program prompt questions about the program's fairness to companies big and small.
By MobiHealthNews | 03:45 pm | September 11, 2018
The agency has reinvented the process for clearing digital health products but reviews are mixed.